Eli Lilly said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the ...
Wegovy maker Novo Nordisk is planning to test its experimental obesity drug, CagriSema, in overweight children and ...
The Zepbound price cut is the latest move in a price war with Denmark’s Novo Nordisk, which is making it significantly less ...
Experts unpack the implications of CBER Director Vinay Prasad’s claim that COVID vaccines have caused 10+ child deaths; the ...
Lilly's Zepbound price cuts ranged from $50 to $100, depending on the dosage, for consumers who pay cash via the drugmaker's LillyDirect website.
US pharma major Eli Lilly (NYSE: LLY) has lowered the price of Zepbound (tirzepatide) single-dose vials on its Lilly Direct ...
The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health ...
The pharmaceutical giant and Novo Nordisk said they would lower the prices of their popular weight loss drugs to expand ...
The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity.
Eli Lilly & Co. and Novo Nordisk A/S plan to start selling their popular obesity shots to employers through a new approach ...
The pharma giant said amycretin helped patients lose weight and reduce blood-sugar levels in pill and injection forms during ...
MedPage Today on MSN
GLP-1 Drugs for Cats? High-Dose Wegovy Heads to FDA; Smartphone-Obesity Link in Kids
Novo Nordisk submitted a higher-dose version of semaglutide (Wegovy) to the FDA for approval as a weight-management treatment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback